Skip to content

Obsessive compulsive symptoms in psychosis: Insight into dynamic interaction and symptom variability

Obsessive compulsive symptoms in psychosis: Insight into dynamic interaction and symptom variability - Obsessive compulsive symptoms in psychosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON38485
Enrollment
220
Registered
2013-11-11
Start date
2014-05-21
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

psychotic disorders schizophrenia

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1) former GROUP participants, who have given informed consent to be contacted for future studies 2) Age range of 18 to 60 years 3) Diagnosis of non-affective psychotic disorder according to the Diagnostic and Statistical Manual of Mental Disorders 4) Previously reported co-morbid obsessive-compulsive symptoms 5) Good command of the Dutch language 6) Able and willing to give written informed consent 7) Internet access. Additional Inclusion criterion for the experience sampling approach will be the change in OCS severity during the previous month. Significant change is defined as a delta Y-BOCS score of 5 or more.

Exclusion criteria

Exclusion criteria: 1) IQ

Design outcomes

Primary

MeasureTime frame
Web-based assessments with monthly assessment intervals over 12 months including psychopathology (psychosis, OCS and affective symptoms), environmental and individual factors (such as life events and coping strategies).

Secondary

MeasureTime frame
Subsequent use of the experience sampling method (ESM) over a period of 6 days in a subgroup of patients with a non-affective psychosis, who recently reported changes in OCS severity.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)